Dear AsCNP members:
It is my honor to serve as AsCNP President from January 1, 2019, to December 31, 2020. This is thefirst of my AsCNP Presidential Correspondence that will be sent every quarter during each year ofmy term.
I encourage you to visit the AsCNP website, which is frequently updated: http://ascnp.org/index.html
Following are the new board members of AsCNP:
A. Executive Committee---------------------------------------------------------------AsCNP Executive Committee (January 1, 2019 - December 31, 2020)
President
Kazutaka Ikeda (Japan)
President-electPast-President
Honorary President
Vice-President
Vice-President

Chay Hoon Tan (Singapore)
Andi J. Tanra (Indonesia)
Shigeto Yamawaki (Japan)
Tianmei Si (China)
Chan-Hyung Kim (Korea)

Vice-President
Shih-Ku Lin (Taiwan)
Secretary of Central Office
Atsumi Nitta (Japan)---------------------------------------------------------------------------------------------------------------------B. Council Members1) to December 31, 2020
Yanling He (China), Gang Zhu (China), Naren Rao (India), Andi J. Tanra (Indonesia), Kazutaka
Ikeda (Japan), Norio Ozaki (Japan), Kiyofumi Yamada (Japan), Won-Myong Bahk (Korea),
Young-Chul Chung (Korea), Chay Hoon Tan (Singapore), Ya-Mei Bai (Taiwan), Lih-Chu Chiou(Taiwan)2) to December 31, 2022
Suresh Sundram (Australia), Tianmei Si (China), Yan Zhang (China), Eric Y.H. Chen (Hong Kong),
Kristian Liaury (Indonesia), Shigenobu Kanba (Japan), Hisatsugu Miyata (Japan), Kazutaka
Shimoda (Japan), Chan Hyung Kim (Korea), Sangyeol Lee (Korea), Kyung Joon Min (Korea),
Johnny Lokin (Philippine), Gavin S. Dawe (Singapore), Ming-Chyi Huang (Taiwan), Shih-Ku Lin(Taiwan), Yen-Kuang Yang (Taiwan), Manit Srisurapanont (Thailand)
C. Auditor (to December 31, 2020)
Toshikazu Saito (Japan), tosaito@hokujin.or.jp
D. Adviser (to December 31, 2022)
Xin Yu (China), Tung-Ping Tom Su (Taiwan), Winston W. Shen (Taiwan)

In 2019, AsCNP will hold two congresses:
AsCNP-ASEAN Congress
Yogyakarta, Indonesia
February 28 to March 2, 2019http://ascnp-asean2019.com/
This congress is mainly for neuropsychopharmacologists and clinicians in ASEAN. The congresschair is Prof. Andi J. Tanra, AsCNP Past-President. We expect more than 400 participants.
6th Congress of AsCNP
Fukuoka, JapanOctober 11-13, 2019https://www2.aeplan.co.jp/ascnp/index.html
Registration for participation and abstract submission starts in January. The deadline for Early Bird
Registration is February 28. The deadline for Abstract Submission is May 31, 2019. Three Plenary
Lectures and approximately 60 symposia have been organized for the AsCNP 2019 Congress.
In 2021, the 7th AsCNP Congress will be held in Singapore. In October 2018, Prof. Tanra (AsCNP
President at that time), Prof. Nitta (AsCNP Executive Secretary), and I visited Singapore and planned
the new AsCNP Board and action plans for 2019 with Prof. Tan (AsCNP President-elect), Prof.
Dawe (AsCNP Councilor), and other important Singapore neuropsychopharmacologists (Photo 1).
The Pharmaceutical Society of Singapore (PSS) Neuropsychopharmacology Section was establishedin 2018 and became a Society Member of AsCNP in 2019.
During my term as President, I would like to strengthen the relationships between each member
society and AsCNP and between AsCNP and other neuropsychopharmacology colleges, such as theCollegium Internationale Neuro-Psychopharmacologicum (CINP), American College of
Neuropsychopharmacology (ACNP), and European College of Neuropsychopharmacology (ECNP).
I am a CINP Executive Committee member and Chair of the CINP Credential and MembershipCommittee. The CINP Executive Committee has decided to automatically approve CINP
membership applications from AsCNP members. I would like AsCNP members to apply for CINP
membership. For ACNP, AsCNP has six slots for participation in the ACNP Annual Meeting. AsCNP
has also been invited to ACNP/AsCNP/CINP/ECNP Leadership Meetings that are held at the ACNP
Annual Meetings. In December 2018, Dr. Shih-Ku Lin (Vice-President of AsCNP and Vice-Presidentof CINP) and I participated in the Leadership Meeting in Florida (Photo 2). For ECNP, AsCNP iscontributing to activities for Neuroscience-based Nomenclature (NbN) for central nervous system
drugs.

My goals during my term as President are to increase AsCNP membership to more than 3000,
increase the number of member countries/regions to more than 15, strengthen alliances among
governments, industry, and academia in Asian neuropsychopharmacology fields and AsCNP
financial bases, and organize several AsCNP committees. I welcome AsCNP members’ ideas for
AsCNP management.
AsCNP President (2019, 2020)
Kazutaka Ikeda
January, 2019

Photo 1: AsCNP Singapore visit in 2018
Gavin Dawe, Atsumi Nitta, Andi Tanra, Kazutaka Ikeda, Chay Hoon Tan, John Wong

Photo 2: ACNP/AsCNP/CINP/ECNP Leadership Meeting held at ACNP 2018
(Top) Kazutaka Ikeda, Siegfried Kasper, Pierre Blier, Shih-Ku Lin, Steve Hyman(Bottom) Alan Frazer, Celso Arango, Anissa Abi-Dargham, Marina Wolf, Joseph Zohar, David Kupfer